Zehong Miao

Introduction

Zehong Miao is a prominent inventor based in Shanghai, China, recognized for his contributions to pharmaceutical innovations. With a portfolio of eight patents, Miao has played a significant role in advancing drug formulation techniques, particularly in solid dispersions and polymorphs.

Latest Patents

Among Miao's latest patents are two groundbreaking innovations. The first is the SOMCL-9112 solid dispersion and its preparation method. This patent details a solid dispersion characterized by varying percentages of SOMCL-9112, a pharmaceutically acceptable matrix polymer, surfactants, flow aids, and plasticizers. The solid dispersion aims to improve medicative efficacy for cancer treatment.

The second patent pertains to a 2-[4-(methylaminomethyl)phenyl]-5-fluoro-benzofuran-7-carboxamide hydrochloride polymorph. This invention discloses three distinct crystalline forms, designated A, B, and C, along with their respective preparation methods and applications in drug development.

Career Highlights

Zehong Miao's career includes significant tenures at notable institutions. He has been associated with the Chinese Academy of Sciences, contributing to research and development initiatives. Additionally, Miao has worked at Cisen Pharmaceutical Co., Ltd., where he further honed his expertise in pharmaceutical innovation.

Collaborations

Throughout his career, Miao has collaborated with esteemed colleagues such as Jian Ding and Yi Chen. These collaborations have played a vital role in enhancing the research output and patent filings associated with Miao's innovations.

Conclusion

Zehong Miao continues to be a driving force in the field of pharmaceutical inventions, with his recent patents paving the way for advancements in cancer treatments. His innovative approaches reflect a commitment to improving healthcare through scientific research and development. As he continues his work, Miao's contributions are set to have a lasting impact on the pharmaceutical industry.